

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ensheathment of neurons (GO:0007272) | 6.68823210 |
| 2 | axon ensheathment (GO:0008366) | 6.68823210 |
| 3 | myelination (GO:0042552) | 6.65796929 |
| 4 | fatty acid elongation (GO:0030497) | 6.64833862 |
| 5 | regulation of vitamin D biosynthetic process (GO:0060556) | 6.24667597 |
| 6 | long-chain fatty acid biosynthetic process (GO:0042759) | 5.74207575 |
| 7 | response to peptidoglycan (GO:0032494) | 5.46517611 |
| 8 | cellular response to zinc ion (GO:0071294) | 5.44509678 |
| 9 | myelin maintenance (GO:0043217) | 5.25778583 |
| 10 | regulation of vitamin metabolic process (GO:0030656) | 4.99720753 |
| 11 | negative regulation of interleukin-12 production (GO:0032695) | 4.90684598 |
| 12 | regulation of cytokine secretion involved in immune response (GO:0002739) | 4.83303544 |
| 13 | positive regulation of chemokine biosynthetic process (GO:0045080) | 4.80881799 |
| 14 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.75047672 |
| 15 | oligodendrocyte differentiation (GO:0048709) | 4.70537689 |
| 16 | positive regulation of heat generation (GO:0031652) | 4.64995722 |
| 17 | regulation of chemokine biosynthetic process (GO:0045073) | 4.59730711 |
| 18 | negative regulation of protein localization to cell surface (GO:2000009) | 4.58897315 |
| 19 | regulation of fever generation (GO:0031620) | 4.57907709 |
| 20 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.55898990 |
| 21 | negative regulation of neurotransmitter secretion (GO:0046929) | 4.55305877 |
| 22 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.52482721 |
| 23 | negative regulation of neurotransmitter transport (GO:0051589) | 4.45300618 |
| 24 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.45095051 |
| 25 | cellular response to type I interferon (GO:0071357) | 4.22143706 |
| 26 | type I interferon signaling pathway (GO:0060337) | 4.22143706 |
| 27 | astrocyte development (GO:0014002) | 4.21193753 |
| 28 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 4.19901205 |
| 29 | response to type I interferon (GO:0034340) | 4.14914871 |
| 30 | regulation of collateral sprouting (GO:0048670) | 4.13784659 |
| 31 | creatine metabolic process (GO:0006600) | 4.12925742 |
| 32 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 4.08507254 |
| 33 | presynaptic membrane organization (GO:0097090) | 4.06789085 |
| 34 | import into cell (GO:0098657) | 3.99784791 |
| 35 | positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.98599652 |
| 36 | regulation of chronic inflammatory response (GO:0002676) | 3.98091189 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 3.96474215 |
| 38 | regulation of interferon-alpha production (GO:0032647) | 3.96459514 |
| 39 | glycerophospholipid catabolic process (GO:0046475) | 3.95212381 |
| 40 | establishment of mitochondrion localization (GO:0051654) | 3.89938697 |
| 41 | response to redox state (GO:0051775) | 3.87660207 |
| 42 | eye photoreceptor cell differentiation (GO:0001754) | 3.82589905 |
| 43 | photoreceptor cell differentiation (GO:0046530) | 3.82589905 |
| 44 | apical protein localization (GO:0045176) | 3.78562729 |
| 45 | asymmetric protein localization (GO:0008105) | 3.76826806 |
| 46 | limb bud formation (GO:0060174) | 3.75969534 |
| 47 | cellular response to cadmium ion (GO:0071276) | 3.71766508 |
| 48 | cholesterol biosynthetic process (GO:0006695) | 3.70899277 |
| 49 | regulation of nitric oxide biosynthetic process (GO:0045428) | 3.69576568 |
| 50 | L-amino acid import (GO:0043092) | 3.69156601 |
| 51 | myelination in peripheral nervous system (GO:0022011) | 3.68923638 |
| 52 | peripheral nervous system axon ensheathment (GO:0032292) | 3.68923638 |
| 53 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.68483244 |
| 54 | positive regulation of osteoblast proliferation (GO:0033690) | 3.68481424 |
| 55 | regulation of mononuclear cell migration (GO:0071675) | 3.67692971 |
| 56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 3.66375334 |
| 57 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.63739428 |
| 58 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.58147679 |
| 59 | regulation of heat generation (GO:0031650) | 3.57694831 |
| 60 | opsonization (GO:0008228) | 3.56431921 |
| 61 | presynaptic membrane assembly (GO:0097105) | 3.55779141 |
| 62 | response to methylmercury (GO:0051597) | 3.51154877 |
| 63 | response to lipoprotein particle (GO:0055094) | 3.50613341 |
| 64 | neuron remodeling (GO:0016322) | 3.49059255 |
| 65 | regulation of podosome assembly (GO:0071801) | 3.47468460 |
| 66 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.46656390 |
| 67 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.44957389 |
| 68 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.44031470 |
| 69 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.39982495 |
| 70 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.39982495 |
| 71 | modulation by symbiont of host immune response (GO:0052553) | 3.39982495 |
| 72 | positive regulation by symbiont of host defense response (GO:0052509) | 3.39982495 |
| 73 | modulation by symbiont of host defense response (GO:0052031) | 3.39982495 |
| 74 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.39982495 |
| 75 | amyloid precursor protein metabolic process (GO:0042982) | 3.38577983 |
| 76 | NIK/NF-kappaB signaling (GO:0038061) | 3.37007634 |
| 77 | positive regulation of interferon-alpha production (GO:0032727) | 3.36029625 |
| 78 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.34913936 |
| 79 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.34207918 |
| 80 | adhesion of symbiont to host cell (GO:0044650) | 3.33629375 |
| 81 | virion attachment to host cell (GO:0019062) | 3.33629375 |
| 82 | GPI anchor biosynthetic process (GO:0006506) | 3.33283182 |
| 83 | positive regulation of type 2 immune response (GO:0002830) | 3.31657126 |
| 84 | isoprenoid biosynthetic process (GO:0008299) | 3.28799668 |
| 85 | sterol biosynthetic process (GO:0016126) | 3.28693363 |
| 86 | regulation of T-helper cell differentiation (GO:0045622) | 3.28495690 |
| 87 | detection of molecule of bacterial origin (GO:0032490) | 3.28355758 |
| 88 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.28206641 |
| 89 | T-helper 1 type immune response (GO:0042088) | 3.25655196 |
| 90 | negative regulation of JUN kinase activity (GO:0043508) | 3.19570336 |
| 91 | germinal center formation (GO:0002467) | 3.19169194 |
| 92 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 3.18655001 |
| 93 | GPI anchor metabolic process (GO:0006505) | 3.18645113 |
| 94 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.18548689 |
| 95 | protein palmitoylation (GO:0018345) | 3.16887610 |
| 96 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 3.15955966 |
| 97 | defense response to protozoan (GO:0042832) | 3.15516062 |
| 98 | cellular response to lipopolysaccharide (GO:0071222) | 3.15025171 |
| 99 | negative regulation of lipid storage (GO:0010888) | 3.14987520 |
| 100 | positive regulation of acute inflammatory response (GO:0002675) | 3.13650272 |
| 101 | extracellular matrix assembly (GO:0085029) | 3.12809127 |
| 102 | positive regulation of chemokine production (GO:0032722) | 3.10147823 |
| 103 | positive regulation of interleukin-6 production (GO:0032755) | 3.09864013 |
| 104 | membrane raft organization (GO:0031579) | 3.09618973 |
| 105 | response to protozoan (GO:0001562) | 3.09393391 |
| 106 | axon development (GO:0061564) | 3.09287634 |
| 107 | regulation of NF-kappaB import into nucleus (GO:0042345) | 3.08643098 |
| 108 | regulation of lipoprotein metabolic process (GO:0050746) | 3.07864812 |
| 109 | cellular response to molecule of bacterial origin (GO:0071219) | 3.07108731 |
| 110 | negative regulation of viral genome replication (GO:0045071) | 3.04819323 |
| 111 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.02796725 |
| 112 | response to interferon-alpha (GO:0035455) | 3.02433569 |
| 113 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.02370204 |
| 114 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.01140527 |
| 115 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.00410778 |
| 116 | substantia nigra development (GO:0021762) | 3.00352241 |
| 117 | response to muramyl dipeptide (GO:0032495) | 2.99732474 |
| 118 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.99185822 |
| 119 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.97855340 |
| 120 | positive regulation of glial cell differentiation (GO:0045687) | 2.97198664 |
| 121 | positive regulation of defense response to virus by host (GO:0002230) | 2.96498047 |
| 122 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.96452721 |
| 123 | protein neddylation (GO:0045116) | 2.94873741 |
| 124 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.94753868 |
| 125 | positive regulation of interferon-beta production (GO:0032728) | 2.94447902 |
| 126 | regulation of interleukin-12 production (GO:0032655) | 2.93865295 |
| 127 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.92730208 |
| 128 | modulation of growth of symbiont involved in interaction with host (GO:0044144) | 2.92406574 |
| 129 | regulation of growth of symbiont in host (GO:0044126) | 2.92406574 |
| 130 | negative regulation of growth of symbiont in host (GO:0044130) | 2.92406574 |
| 131 | negative regulation of growth of symbiont involved in interaction with host (GO:0044146) | 2.92406574 |
| 132 | membrane tubulation (GO:0097320) | 2.92274551 |
| 133 | monocyte chemotaxis (GO:0002548) | 2.90115768 |
| 134 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.88010821 |
| 135 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.87980558 |
| 136 | regulation of immunoglobulin secretion (GO:0051023) | 2.86497979 |
| 137 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.86383303 |
| 138 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.85786071 |
| 139 | regulation of heterotypic cell-cell adhesion (GO:0034114) | 2.83537475 |
| 140 | glial cell development (GO:0021782) | 2.83356559 |
| 141 | cellular response to interferon-gamma (GO:0071346) | 2.81580244 |
| 142 | iron ion import (GO:0097286) | 2.80054442 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.79531142 |
| 144 | regulation of osteoblast proliferation (GO:0033688) | 2.79278772 |
| 145 | nucleotide transmembrane transport (GO:1901679) | 2.79077111 |
| 146 | response to interferon-beta (GO:0035456) | 2.78916449 |
| 147 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 2.78751651 |
| 148 | cellular response to interferon-alpha (GO:0035457) | 2.78647636 |
| 149 | peripheral nervous system development (GO:0007422) | 2.78595306 |
| 150 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.77580352 |
| 151 | regulation of type 2 immune response (GO:0002828) | 2.77477843 |
| 152 | neutrophil activation involved in immune response (GO:0002283) | 2.77129816 |
| 153 | response to interferon-gamma (GO:0034341) | 2.75754619 |
| 154 | negative regulation of acute inflammatory response (GO:0002674) | 2.75541613 |
| 155 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.74605355 |
| 156 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.74477535 |
| 157 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.74282778 |
| 158 | positive regulation of lipid storage (GO:0010884) | 2.72618678 |
| 159 | lateral sprouting from an epithelium (GO:0060601) | 2.72517922 |
| 160 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.71265570 |
| 161 | adult walking behavior (GO:0007628) | 2.71038395 |
| 162 | enteric nervous system development (GO:0048484) | 2.70378517 |
| 163 | response to lead ion (GO:0010288) | 2.69619963 |
| 164 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.68706644 |
| 165 | regulation of interleukin-6 production (GO:0032675) | 2.67576283 |
| 166 | cellular response to biotic stimulus (GO:0071216) | 2.67543566 |
| 167 | negative regulation of chemokine production (GO:0032682) | 2.67416339 |
| 168 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.67184489 |
| 169 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.66282114 |
| 170 | eosinophil chemotaxis (GO:0048245) | 2.66184716 |
| 171 | response to manganese ion (GO:0010042) | 2.65311439 |
| 172 | positive regulation of gliogenesis (GO:0014015) | 2.65263690 |
| 173 | organ growth (GO:0035265) | 2.65088926 |
| 174 | granulocyte activation (GO:0036230) | 2.64907922 |
| 175 | neuron cell-cell adhesion (GO:0007158) | 2.63927860 |
| 176 | extracellular fibril organization (GO:0043206) | 2.63141999 |
| 177 | negative regulation of axonogenesis (GO:0050771) | 2.62414791 |
| 178 | amino acid import (GO:0043090) | 2.62158066 |
| 179 | positive regulation of macrophage cytokine production (GO:0060907) | 2.60679735 |
| 180 | otic vesicle formation (GO:0030916) | 2.60356403 |
| 181 | magnesium ion transport (GO:0015693) | 2.59896522 |
| 182 | neurotransmitter uptake (GO:0001504) | 2.59287159 |
| 183 | tissue regeneration (GO:0042246) | 2.58742076 |
| 184 | mannosylation (GO:0097502) | 2.58637555 |
| 185 | glial cell differentiation (GO:0010001) | 2.57165856 |
| 186 | microtubule polymerization or depolymerization (GO:0031109) | 2.55639865 |
| 187 | cyclic nucleotide catabolic process (GO:0009214) | 2.53170044 |
| 188 | regulation of pigment cell differentiation (GO:0050932) | 2.52317168 |
| 189 | negative regulation of macroautophagy (GO:0016242) | 2.47469649 |
| 190 | very long-chain fatty acid metabolic process (GO:0000038) | 2.44940289 |
| 191 | adhesion of symbiont to host (GO:0044406) | 2.44201744 |
| 192 | amyloid precursor protein catabolic process (GO:0042987) | 2.43690311 |
| 193 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.43536130 |
| 194 | membrane assembly (GO:0071709) | 2.42669970 |
| 195 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.41090100 |
| 196 | negative regulation of inclusion body assembly (GO:0090084) | 2.38162090 |
| 197 | positive regulation of action potential (GO:0045760) | 2.37889992 |
| 198 | positive regulation of pseudopodium assembly (GO:0031274) | 2.37813803 |
| 199 | axon ensheathment in central nervous system (GO:0032291) | 12.4279134 |
| 200 | central nervous system myelination (GO:0022010) | 12.4279134 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.99658945 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47471759 |
| 3 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 4.39470936 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.01189340 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.72610123 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.60157549 |
| 7 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28795905 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.20242954 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.18029313 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.01884335 |
| 11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.99129317 |
| 12 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.93656049 |
| 13 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.87474057 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.79246785 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.70959149 |
| 16 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.69492375 |
| 17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.57062362 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.47859898 |
| 19 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.44760320 |
| 20 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.43005395 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.39003740 |
| 22 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.37968637 |
| 23 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.34993589 |
| 24 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.27169536 |
| 25 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.24410023 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.24336776 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.18380770 |
| 28 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.17031726 |
| 29 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.16229479 |
| 30 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.13989914 |
| 31 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12405267 |
| 32 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.11118788 |
| 33 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.11118788 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.10512805 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05276051 |
| 36 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.03370033 |
| 37 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.03075409 |
| 38 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.02533825 |
| 39 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02281274 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.96113062 |
| 41 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.95881341 |
| 42 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.94353594 |
| 43 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.93906753 |
| 44 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.89275840 |
| 45 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.88399284 |
| 46 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.83978001 |
| 47 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.80640427 |
| 48 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.78172036 |
| 49 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.77620455 |
| 50 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.76530009 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.74872331 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.73143640 |
| 53 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.73027126 |
| 54 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.72896198 |
| 55 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.69689530 |
| 56 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.67169914 |
| 57 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.66231110 |
| 58 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.65107125 |
| 59 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64840808 |
| 60 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.62025189 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.57610010 |
| 62 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.56625870 |
| 63 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.56407104 |
| 64 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.55296430 |
| 65 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.52200946 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.48984903 |
| 67 | SPI1_23127762_ChIP-Seq_K562_Human | 1.48748738 |
| 68 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48468053 |
| 69 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47824584 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.46278077 |
| 71 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.46052779 |
| 72 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.44203427 |
| 73 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43783004 |
| 74 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.43004730 |
| 75 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.42650707 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41380271 |
| 77 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.41019486 |
| 78 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.41019486 |
| 79 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.41019486 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.40517045 |
| 81 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.40517045 |
| 82 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40259425 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.39788501 |
| 84 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.38727235 |
| 85 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.35181521 |
| 86 | P300_19829295_ChIP-Seq_ESCs_Human | 1.34301670 |
| 87 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.33493060 |
| 88 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.31787229 |
| 89 | VDR_22108803_ChIP-Seq_LS180_Human | 1.31242410 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.30490398 |
| 91 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28927331 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.27723866 |
| 93 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.26024088 |
| 94 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.25943303 |
| 95 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.25839050 |
| 96 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.23426275 |
| 97 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.22198703 |
| 98 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21655286 |
| 99 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.21030657 |
| 100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.20823233 |
| 101 | GATA1_22025678_ChIP-Seq_K562_Human | 1.19732932 |
| 102 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.18231001 |
| 103 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16981207 |
| 104 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.16957396 |
| 105 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16737069 |
| 106 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.16407244 |
| 107 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15844552 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.15754584 |
| 109 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.14986333 |
| 110 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.14810550 |
| 111 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14341828 |
| 112 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.13068038 |
| 113 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13007026 |
| 114 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.12489006 |
| 115 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.12463831 |
| 116 | MYB_26560356_Chip-Seq_TH2_Human | 1.11101292 |
| 117 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10050701 |
| 118 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.09680195 |
| 119 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.09447759 |
| 120 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.08304460 |
| 121 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08061966 |
| 122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.07397923 |
| 123 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07210081 |
| 124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.06203650 |
| 125 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.06026679 |
| 126 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05662772 |
| 127 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.05039343 |
| 128 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.04802267 |
| 129 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.04361390 |
| 130 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.03969211 |
| 131 | CJUN_26792858_Chip-Seq_BT549_Human | 1.03868436 |
| 132 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.03724959 |
| 133 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.02790130 |
| 134 | MAF_26560356_Chip-Seq_TH1_Human | 1.02426785 |
| 135 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.01910637 |
| 136 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.00939401 |
| 137 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.00702938 |
| 138 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.00693891 |
| 139 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00348998 |
| 140 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.99444806 |
| 141 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.98911556 |
| 142 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.98654699 |
| 143 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.98432181 |
| 144 | GATA3_26560356_Chip-Seq_TH2_Human | 0.98023045 |
| 145 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97605675 |
| 146 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.97577030 |
| 147 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.97486103 |
| 148 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.96949699 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96736103 |
| 150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.96491840 |
| 151 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.95272986 |
| 152 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.95016264 |
| 153 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.94983415 |
| 154 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.94875310 |
| 155 | MYB_26560356_Chip-Seq_TH1_Human | 0.94638608 |
| 156 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.94065358 |
| 157 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.93828158 |
| 158 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.93593578 |
| 159 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.93243235 |
| 160 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.93240469 |
| 161 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.93131283 |
| 162 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.93003843 |
| 163 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92604329 |
| 164 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92433296 |
| 165 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.92358648 |
| 166 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.92258075 |
| 167 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.92198498 |
| 168 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.92198498 |
| 169 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.91648738 |
| 170 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91572357 |
| 171 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.91338403 |
| 172 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.90648274 |
| 173 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.90605978 |
| 174 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.90461226 |
| 175 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.90293936 |
| 176 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.90012611 |
| 177 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.88974909 |
| 178 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.86312151 |
| 179 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.86104581 |
| 180 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.83011647 |
| 181 | TP53_16413492_ChIP-PET_HCT116_Human | 0.81358669 |
| 182 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.78383283 |
| 183 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.78361679 |
| 184 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.77734717 |
| 185 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.77608192 |
| 186 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.71970364 |
| 187 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.71646426 |
| 188 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.70966477 |
| 189 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.70714595 |
| 190 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.69858641 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 5.59490560 |
| 2 | MP0000920_abnormal_myelination | 5.33403622 |
| 3 | MP0003950_abnormal_plasma_membrane | 4.27026970 |
| 4 | MP0008438_abnormal_cutaneous_collagen | 3.88936702 |
| 5 | MP0004510_myositis | 3.48600320 |
| 6 | MP0009785_altered_susceptibility_to | 3.42157413 |
| 7 | MP0005171_absent_coat_pigmentation | 3.36949842 |
| 8 | MP0003436_decreased_susceptibility_to | 3.28556976 |
| 9 | MP0003136_yellow_coat_color | 3.20558625 |
| 10 | MP0005503_abnormal_tendon_morphology | 3.19581423 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 3.14749776 |
| 12 | MP0003880_abnormal_central_pattern | 2.96516311 |
| 13 | MP0003690_abnormal_glial_cell | 2.93064537 |
| 14 | MP0004270_analgesia | 2.81695878 |
| 15 | MP0009764_decreased_sensitivity_to | 2.58512671 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.46426775 |
| 17 | MP0001835_abnormal_antigen_presentation | 2.44123133 |
| 18 | MP0004742_abnormal_vestibular_system | 2.39169334 |
| 19 | MP0005000_abnormal_immune_tolerance | 2.38861774 |
| 20 | MP0002419_abnormal_innate_immunity | 2.36104072 |
| 21 | MP0005025_abnormal_response_to | 2.28692495 |
| 22 | MP0009278_abnormal_bone_marrow | 2.26519384 |
| 23 | MP0000343_altered_response_to | 2.26418934 |
| 24 | MP0003075_altered_response_to | 2.25776778 |
| 25 | MP0005387_immune_system_phenotype | 2.25154189 |
| 26 | MP0001790_abnormal_immune_system | 2.25154189 |
| 27 | MP0002254_reproductive_system_inflammat | 2.24228780 |
| 28 | MP0008004_abnormal_stomach_pH | 2.23423054 |
| 29 | MP0004885_abnormal_endolymph | 2.22884160 |
| 30 | MP0001529_abnormal_vocalization | 2.14671211 |
| 31 | MP0001486_abnormal_startle_reflex | 2.13311636 |
| 32 | MP0003634_abnormal_glial_cell | 2.12402012 |
| 33 | MP0005275_abnormal_skin_tensile | 2.09454920 |
| 34 | MP0002272_abnormal_nervous_system | 2.07310467 |
| 35 | MP0004134_abnormal_chest_morphology | 2.06938452 |
| 36 | MP0001533_abnormal_skeleton_physiology | 2.06443764 |
| 37 | MP0005409_darkened_coat_color | 2.06194400 |
| 38 | MP0003279_aneurysm | 2.04895314 |
| 39 | MP0001905_abnormal_dopamine_level | 1.99899079 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.97827759 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.97827759 |
| 42 | MP0002332_abnormal_exercise_endurance | 1.97722468 |
| 43 | MP0003329_amyloid_beta_deposits | 1.91305205 |
| 44 | MP0002452_abnormal_antigen_presenting | 1.87540575 |
| 45 | MP0004947_skin_inflammation | 1.87401810 |
| 46 | MP0002723_abnormal_immune_serum | 1.85373102 |
| 47 | MP0005671_abnormal_response_to | 1.84047664 |
| 48 | MP0004142_abnormal_muscle_tone | 1.83162633 |
| 49 | MP0005167_abnormal_blood-brain_barrier | 1.79357765 |
| 50 | MP0001800_abnormal_humoral_immune | 1.79045337 |
| 51 | MP0003656_abnormal_erythrocyte_physiolo | 1.76103666 |
| 52 | MP0001853_heart_inflammation | 1.75965283 |
| 53 | MP0001485_abnormal_pinna_reflex | 1.75635678 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.74116163 |
| 55 | MP0003195_calcinosis | 1.72801527 |
| 56 | MP0000778_abnormal_nervous_system | 1.72408807 |
| 57 | MP0005058_abnormal_lysosome_morphology | 1.71551657 |
| 58 | MP0005166_decreased_susceptibility_to | 1.68210995 |
| 59 | MP0006054_spinal_hemorrhage | 1.66948163 |
| 60 | MP0004381_abnormal_hair_follicle | 1.66284215 |
| 61 | MP0003448_altered_tumor_morphology | 1.64128697 |
| 62 | MP0002405_respiratory_system_inflammati | 1.62937898 |
| 63 | MP0004043_abnormal_pH_regulation | 1.61668957 |
| 64 | MP0000462_abnormal_digestive_system | 1.59631732 |
| 65 | MP0009840_abnormal_foam_cell | 1.56769353 |
| 66 | MP0008469_abnormal_protein_level | 1.56431123 |
| 67 | MP0002064_seizures | 1.56336116 |
| 68 | MP0010155_abnormal_intestine_physiology | 1.55242061 |
| 69 | MP0003453_abnormal_keratinocyte_physiol | 1.53644660 |
| 70 | * MP0005410_abnormal_fertilization | 1.50368003 |
| 71 | MP0009250_abnormal_appendicular_skeleto | 1.50324838 |
| 72 | MP0002933_joint_inflammation | 1.50179821 |
| 73 | MP0000383_abnormal_hair_follicle | 1.48579275 |
| 74 | MP0005023_abnormal_wound_healing | 1.48025716 |
| 75 | MP0000685_abnormal_immune_system | 1.47961230 |
| 76 | MP0003632_abnormal_nervous_system | 1.47700857 |
| 77 | MP0002295_abnormal_pulmonary_circulatio | 1.45086197 |
| 78 | MP0002998_abnormal_bone_remodeling | 1.43207476 |
| 79 | MP0001819_abnormal_immune_cell | 1.43006927 |
| 80 | MP0005423_abnormal_somatic_nervous | 1.42207922 |
| 81 | MP0009333_abnormal_splenocyte_physiolog | 1.42154452 |
| 82 | MP0002420_abnormal_adaptive_immunity | 1.41682188 |
| 83 | MP0000566_synostosis | 1.41202388 |
| 84 | MP0000762_abnormal_tongue_morphology | 1.39636517 |
| 85 | MP0003091_abnormal_cell_migration | 1.39405140 |
| 86 | MP0002108_abnormal_muscle_morphology | 1.37868763 |
| 87 | MP0002229_neurodegeneration | 1.37266416 |
| 88 | MP0003191_abnormal_cellular_cholesterol | 1.36423941 |
| 89 | MP0002734_abnormal_mechanical_nocicepti | 1.33464602 |
| 90 | MP0010678_abnormal_skin_adnexa | 1.33071542 |
| 91 | MP0005451_abnormal_body_composition | 1.28462378 |
| 92 | MP0002139_abnormal_hepatobiliary_system | 1.27175262 |
| 93 | MP0005623_abnormal_meninges_morphology | 1.26698343 |
| 94 | MP0001346_abnormal_lacrimal_gland | 1.26069983 |
| 95 | MP0001299_abnormal_eye_distance/ | 1.23816075 |
| 96 | MP0009046_muscle_twitch | 1.23344931 |
| 97 | MP0003806_abnormal_nucleotide_metabolis | 1.22072657 |
| 98 | MP0009763_increased_sensitivity_to | 1.19403922 |
| 99 | MP0001958_emphysema | 1.18553888 |
| 100 | MP0001851_eye_inflammation | 1.18044661 |
| 101 | MP0004272_abnormal_basement_membrane | 1.16269103 |
| 102 | MP0001501_abnormal_sleep_pattern | 1.15239016 |
| 103 | MP0008260_abnormal_autophagy | 1.14909815 |
| 104 | MP0001963_abnormal_hearing_physiology | 1.13121001 |
| 105 | MP0005508_abnormal_skeleton_morphology | 1.12535581 |
| 106 | MP0003631_nervous_system_phenotype | 1.12036362 |
| 107 | MP0001879_abnormal_lymphatic_vessel | 1.10048249 |
| 108 | MP0001348_abnormal_lacrimal_gland | 1.09171943 |
| 109 | MP0005310_abnormal_salivary_gland | 1.08532487 |
| 110 | MP0005666_abnormal_adipose_tissue | 1.07720151 |
| 111 | MP0000858_altered_metastatic_potential | 1.07332645 |
| 112 | MP0000955_abnormal_spinal_cord | 1.07106004 |
| 113 | MP0010352_gastrointestinal_tract_polyps | 1.06107566 |
| 114 | MP0003937_abnormal_limbs/digits/tail_de | 1.05731034 |
| 115 | MP0009745_abnormal_behavioral_response | 1.05710093 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 1.05289203 |
| 117 | MP0001661_extended_life_span | 1.03466722 |
| 118 | MP0003938_abnormal_ear_development | 1.02078635 |
| 119 | MP0002752_abnormal_somatic_nervous | 0.97483167 |
| 120 | MP0000716_abnormal_immune_system | 0.97326431 |
| 121 | MP0001177_atelectasis | 0.96788312 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.96754294 |
| 123 | MP0003635_abnormal_synaptic_transmissio | 0.94799227 |
| 124 | MP0003186_abnormal_redox_activity | 0.94684847 |
| 125 | MP0003633_abnormal_nervous_system | 0.93428409 |
| 126 | MP0000647_abnormal_sebaceous_gland | 0.93386604 |
| 127 | MP0003646_muscle_fatigue | 0.93284623 |
| 128 | MP0000747_muscle_weakness | 0.92913992 |
| 129 | MP0004883_abnormal_blood_vessel | 0.91693905 |
| 130 | MP0005165_increased_susceptibility_to | 0.91154238 |
| 131 | MP0002938_white_spotting | 0.90293430 |
| 132 | MP0003724_increased_susceptibility_to | 0.89403164 |
| 133 | MP0000026_abnormal_inner_ear | 0.88622857 |
| 134 | MP0009765_abnormal_xenobiotic_induced | 0.87874665 |
| 135 | MP0002066_abnormal_motor_capabilities/c | 0.87385622 |
| 136 | MP0000604_amyloidosis | 0.87102139 |
| 137 | MP0001970_abnormal_pain_threshold | 0.86624475 |
| 138 | MP0002572_abnormal_emotion/affect_behav | 0.86340007 |
| 139 | MP0001440_abnormal_grooming_behavior | 0.85819056 |
| 140 | MP0008569_lethality_at_weaning | 0.84792777 |
| 141 | MP0005195_abnormal_posterior_eye | 0.84251534 |
| 142 | MP0001542_abnormal_bone_strength | 0.81885633 |
| 143 | MP0002133_abnormal_respiratory_system | 0.81185304 |
| 144 | MP0005388_respiratory_system_phenotype | 0.81185304 |
| 145 | MP0002067_abnormal_sensory_capabilities | 0.80826464 |
| 146 | MP0000579_abnormal_nail_morphology | 0.79768858 |
| 147 | MP0002398_abnormal_bone_marrow | 0.79520091 |
| 148 | MP0000249_abnormal_blood_vessel | 0.78594114 |
| 149 | MP0004859_abnormal_synaptic_plasticity | 0.78194867 |
| 150 | MP0000467_abnormal_esophagus_morphology | 0.77599381 |
| 151 | MP0005408_hypopigmentation | 0.75911071 |
| 152 | MP0005164_abnormal_response_to | 0.73522529 |
| 153 | MP0005595_abnormal_vascular_smooth | 0.72689295 |
| 154 | MP0005464_abnormal_platelet_physiology | 0.72674024 |
| 155 | MP0006082_CNS_inflammation | 0.72661700 |
| 156 | MP0003172_abnormal_lysosome_physiology | 0.71919966 |
| 157 | MP0005647_abnormal_sex_gland | 0.71617371 |
| 158 | MP0002722_abnormal_immune_system | 0.70993311 |
| 159 | MP0002429_abnormal_blood_cell | 0.69769819 |
| 160 | MP0003795_abnormal_bone_structure | 0.68322483 |
| 161 | MP0004924_abnormal_behavior | 0.68306731 |
| 162 | MP0005386_behavior/neurological_phenoty | 0.68306731 |
| 163 | MP0001663_abnormal_digestive_system | 0.66864354 |
| 164 | MP0003705_abnormal_hypodermis_morpholog | 0.66858685 |
| 165 | MP0008874_decreased_physiological_sensi | 0.66676646 |
| 166 | MP0003045_fibrosis | 0.66344372 |
| 167 | MP0005375_adipose_tissue_phenotype | 0.66163507 |
| 168 | MP0004808_abnormal_hematopoietic_stem | 0.66098008 |
| 169 | MP0002249_abnormal_larynx_morphology | 0.65845597 |
| 170 | MP0010368_abnormal_lymphatic_system | 0.65105210 |
| 171 | MP0004147_increased_porphyrin_level | 0.64911837 |
| 172 | MP0003011_delayed_dark_adaptation | 0.64666039 |
| 173 | MP0001340_abnormal_eyelid_morphology | 0.64657955 |
| 174 | MP0005390_skeleton_phenotype | 0.63858571 |
| 175 | MP0000749_muscle_degeneration | 0.63854777 |
| 176 | MP0000689_abnormal_spleen_morphology | 0.63531875 |
| 177 | MP0002063_abnormal_learning/memory/cond | 0.63401745 |
| 178 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63355283 |
| 179 | MP0003828_pulmonary_edema | 0.63082560 |
| 180 | MP0004145_abnormal_muscle_electrophysio | 0.62464043 |
| 181 | MP0001243_abnormal_dermal_layer | 0.62064032 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 6.10166402 |
| 2 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 6.08610308 |
| 3 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 6.08610308 |
| 4 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.05109152 |
| 5 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.05109152 |
| 6 | Abnormality of glycolipid metabolism (HP:0010969) | 6.05109152 |
| 7 | Optic neuritis (HP:0100653) | 5.45926997 |
| 8 | Retrobulbar optic neuritis (HP:0100654) | 5.45926997 |
| 9 | Orchitis (HP:0100796) | 5.37409241 |
| 10 | Myositis (HP:0100614) | 4.79610401 |
| 11 | Peripheral hypomyelination (HP:0007182) | 4.56943187 |
| 12 | Systemic lupus erythematosus (HP:0002725) | 4.45278431 |
| 13 | Sensory axonal neuropathy (HP:0003390) | 4.35059607 |
| 14 | Abnormality of macrophages (HP:0004311) | 4.32429368 |
| 15 | Stomatitis (HP:0010280) | 4.26038669 |
| 16 | Abnormality of the corticospinal tract (HP:0002492) | 4.20845607 |
| 17 | Recurrent bacterial skin infections (HP:0005406) | 4.09909787 |
| 18 | Cerebral inclusion bodies (HP:0100314) | 4.07748405 |
| 19 | Onion bulb formation (HP:0003383) | 3.92806427 |
| 20 | Parakeratosis (HP:0001036) | 3.87710299 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 3.83931328 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.77607035 |
| 23 | Keratoconjunctivitis sicca (HP:0001097) | 3.76242133 |
| 24 | Eczematoid dermatitis (HP:0000976) | 3.74667457 |
| 25 | Increased serum ferritin (HP:0003281) | 3.70432879 |
| 26 | Abnormality of the costochondral junction (HP:0000919) | 3.67302869 |
| 27 | Recurrent abscess formation (HP:0002722) | 3.59656298 |
| 28 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.58923571 |
| 29 | Vacuolated lymphocytes (HP:0001922) | 3.44561631 |
| 30 | Segmental peripheral demyelination/remyelination (HP:0003481) | 3.44406067 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.42589365 |
| 32 | Abnormal auditory evoked potentials (HP:0006958) | 3.35174869 |
| 33 | Alacrima (HP:0000522) | 3.33539213 |
| 34 | Cervical subluxation (HP:0003308) | 3.24343293 |
| 35 | Loss of speech (HP:0002371) | 3.23610335 |
| 36 | Dysostosis multiplex (HP:0000943) | 3.15743658 |
| 37 | Autoimmune thrombocytopenia (HP:0001973) | 3.11956453 |
| 38 | Muscle fiber splitting (HP:0003555) | 3.11353640 |
| 39 | Cerebral hypomyelination (HP:0006808) | 3.09866328 |
| 40 | Gastrointestinal infarctions (HP:0005244) | 3.09753403 |
| 41 | Hematochezia (HP:0002573) | 3.09716522 |
| 42 | Increased cerebral lipofuscin (HP:0011813) | 3.08170961 |
| 43 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.07291467 |
| 44 | Disinhibition (HP:0000734) | 3.00765891 |
| 45 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.96495330 |
| 46 | Amyloidosis (HP:0011034) | 2.95237711 |
| 47 | Premature rupture of membranes (HP:0001788) | 2.93863832 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 2.92991941 |
| 49 | Coronal craniosynostosis (HP:0004440) | 2.92473779 |
| 50 | Abnormality of iron homeostasis (HP:0011031) | 2.92441189 |
| 51 | Gangrene (HP:0100758) | 2.92280598 |
| 52 | Hemoptysis (HP:0002105) | 2.88187604 |
| 53 | Termporal pattern (HP:0011008) | 2.84985267 |
| 54 | Insidious onset (HP:0003587) | 2.84985267 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.84799974 |
| 56 | Thickened helices (HP:0000391) | 2.84447965 |
| 57 | Vasculitis (HP:0002633) | 2.82959770 |
| 58 | Anteriorly placed anus (HP:0001545) | 2.82492099 |
| 59 | Bell-shaped thorax (HP:0001591) | 2.81352910 |
| 60 | Myocardial infarction (HP:0001658) | 2.79288786 |
| 61 | Aplasia involving bones of the extremities (HP:0009825) | 2.78575892 |
| 62 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.78575892 |
| 63 | Aplasia of the phalanges of the hand (HP:0009802) | 2.78575892 |
| 64 | Spastic gait (HP:0002064) | 2.78007870 |
| 65 | Nuclear cataract (HP:0100018) | 2.76852574 |
| 66 | Hypoplasia of the iris (HP:0007676) | 2.75735674 |
| 67 | Glomerulonephritis (HP:0000099) | 2.74879381 |
| 68 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.73836151 |
| 69 | Absent septum pellucidum (HP:0001331) | 2.71421004 |
| 70 | Interstitial pulmonary disease (HP:0006530) | 2.70836712 |
| 71 | Mutism (HP:0002300) | 2.68671693 |
| 72 | Anorexia (HP:0002039) | 2.67799690 |
| 73 | Hypoplastic pelvis (HP:0008839) | 2.66621549 |
| 74 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.64632003 |
| 75 | Decreased lacrimation (HP:0000633) | 2.64621054 |
| 76 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.64116752 |
| 77 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.64116752 |
| 78 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.64116752 |
| 79 | Arterial thrombosis (HP:0004420) | 2.56509578 |
| 80 | Duplicated collecting system (HP:0000081) | 2.51688355 |
| 81 | Stridor (HP:0010307) | 2.51248633 |
| 82 | Autoamputation (HP:0001218) | 2.51240694 |
| 83 | Infantile muscular hypotonia (HP:0008947) | 2.49109622 |
| 84 | Mucopolysacchariduria (HP:0008155) | 2.47866933 |
| 85 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.47866933 |
| 86 | Peritonitis (HP:0002586) | 2.47188182 |
| 87 | Cerebral hemorrhage (HP:0001342) | 2.46233295 |
| 88 | Leukodystrophy (HP:0002415) | 2.45522854 |
| 89 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.44943101 |
| 90 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.44743557 |
| 91 | Foot dorsiflexor weakness (HP:0009027) | 2.44572813 |
| 92 | White forelock (HP:0002211) | 2.42029620 |
| 93 | Metaphyseal irregularity (HP:0003025) | 2.41359990 |
| 94 | Increased IgM level (HP:0003496) | 2.41327708 |
| 95 | Dysmetria (HP:0001310) | 2.41029837 |
| 96 | Episodic fever (HP:0001954) | 2.39620525 |
| 97 | Abnormality of the pleura (HP:0002103) | 2.38435150 |
| 98 | Basal ganglia calcification (HP:0002135) | 2.38193248 |
| 99 | Retinal dysplasia (HP:0007973) | 2.38039989 |
| 100 | Axonal loss (HP:0003447) | 2.37521917 |
| 101 | Glomerulopathy (HP:0100820) | 2.37440930 |
| 102 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.35969469 |
| 103 | Abnormality of the septum pellucidum (HP:0007375) | 2.35881325 |
| 104 | Abnormality of the pericardium (HP:0001697) | 2.34110180 |
| 105 | Patchy hypopigmentation of hair (HP:0011365) | 2.33297329 |
| 106 | Nausea (HP:0002018) | 2.30741959 |
| 107 | Premature skin wrinkling (HP:0100678) | 2.26468330 |
| 108 | Decreased motor nerve conduction velocity (HP:0003431) | 2.25581952 |
| 109 | Apathy (HP:0000741) | 2.24258471 |
| 110 | Polyneuropathy (HP:0001271) | 2.22321267 |
| 111 | Slow saccadic eye movements (HP:0000514) | 2.21930937 |
| 112 | Conical tooth (HP:0000698) | 2.20525032 |
| 113 | Abnormality of the foot musculature (HP:0001436) | 2.20331801 |
| 114 | Spinal cord lesions (HP:0100561) | 2.19217427 |
| 115 | Syringomyelia (HP:0003396) | 2.19217427 |
| 116 | Humeroradial synostosis (HP:0003041) | 2.18534292 |
| 117 | Synostosis involving the elbow (HP:0003938) | 2.18534292 |
| 118 | Scanning speech (HP:0002168) | 2.17024739 |
| 119 | Hypergammaglobulinemia (HP:0010702) | 2.15880554 |
| 120 | Joint swelling (HP:0001386) | 2.15565305 |
| 121 | Recurrent skin infections (HP:0001581) | 2.15120944 |
| 122 | Thin bony cortex (HP:0002753) | 2.14910506 |
| 123 | Myokymia (HP:0002411) | 2.13083651 |
| 124 | Intention tremor (HP:0002080) | 2.12480722 |
| 125 | Flared iliac wings (HP:0002869) | 2.11660820 |
| 126 | Hepatosplenomegaly (HP:0001433) | 2.10830677 |
| 127 | Diminished motivation (HP:0000745) | 2.10533562 |
| 128 | Split foot (HP:0001839) | 2.10516698 |
| 129 | Complement deficiency (HP:0004431) | 2.10255654 |
| 130 | Abnormality of glycolysis (HP:0004366) | 2.09439127 |
| 131 | Increased serum pyruvate (HP:0003542) | 2.09439127 |
| 132 | Abnormality of the renal collecting system (HP:0004742) | 2.08640723 |
| 133 | Septo-optic dysplasia (HP:0100842) | 2.08015121 |
| 134 | Hypophosphatemic rickets (HP:0004912) | 2.07766858 |
| 135 | Recurrent fungal infections (HP:0002841) | 2.07703677 |
| 136 | Autoimmune hemolytic anemia (HP:0001890) | 2.07634938 |
| 137 | Abnormality of dentin (HP:0010299) | 2.07177889 |
| 138 | CNS hypomyelination (HP:0003429) | 2.07107416 |
| 139 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.06906700 |
| 140 | Metabolic alkalosis (HP:0200114) | 2.05353305 |
| 141 | Gingivitis (HP:0000230) | 2.04794806 |
| 142 | T lymphocytopenia (HP:0005403) | 2.04317151 |
| 143 | Pheochromocytoma (HP:0002666) | 2.04169389 |
| 144 | Keratitis (HP:0000491) | 2.03738203 |
| 145 | Broad metatarsal (HP:0001783) | 2.03506229 |
| 146 | Obstructive lung disease (HP:0006536) | 2.03196405 |
| 147 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03196405 |
| 148 | Pulmonary embolism (HP:0002204) | 2.01570640 |
| 149 | Spondylolisthesis (HP:0003302) | 2.01012404 |
| 150 | Clumsiness (HP:0002312) | 1.98994171 |
| 151 | Round ear (HP:0100830) | 1.98470272 |
| 152 | Ankle clonus (HP:0011448) | 1.97872231 |
| 153 | Pulmonary artery stenosis (HP:0004415) | 1.97828987 |
| 154 | Progressive neurologic deterioration (HP:0002344) | 1.97640697 |
| 155 | Azoospermia (HP:0000027) | 1.97570520 |
| 156 | Leukocytosis (HP:0001974) | 1.96861701 |
| 157 | Barrel-shaped chest (HP:0001552) | 1.96687508 |
| 158 | Recurrent viral infections (HP:0004429) | 1.96408996 |
| 159 | Morphological abnormality of the inner ear (HP:0011390) | 1.95672233 |
| 160 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.95507765 |
| 161 | Partial duplication of thumb phalanx (HP:0009944) | 1.95433636 |
| 162 | Abnormality of T cell number (HP:0011839) | 1.95240245 |
| 163 | Spastic paraparesis (HP:0002313) | 1.94268223 |
| 164 | Stomach cancer (HP:0012126) | 1.92476794 |
| 165 | Acne (HP:0001061) | 1.90758135 |
| 166 | Vertigo (HP:0002321) | 1.89800326 |
| 167 | Abnormality of the endocardium (HP:0004306) | 1.89055490 |
| 168 | Petechiae (HP:0000967) | 1.88735174 |
| 169 | Abnormality of complement system (HP:0005339) | 1.88608786 |
| 170 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.88099461 |
| 171 | Abnormality of incisor morphology (HP:0011063) | 1.87679980 |
| 172 | Arthralgia (HP:0002829) | 1.86503227 |
| 173 | Increased IgE level (HP:0003212) | 1.86118512 |
| 174 | Hammertoe (HP:0001765) | 1.84888888 |
| 175 | Encephalitis (HP:0002383) | 1.84736748 |
| 176 | Neuroendocrine neoplasm (HP:0100634) | 1.84679897 |
| 177 | Hyporeflexia of lower limbs (HP:0002600) | 1.83132400 |
| 178 | Malnutrition (HP:0004395) | 1.82998904 |
| 179 | Cupped ribs (HP:0000887) | 1.82769606 |
| 180 | Partial duplication of the phalanx of hand (HP:0009999) | 1.80329967 |
| 181 | Follicular hyperkeratosis (HP:0007502) | 1.79726380 |
| 182 | Prolonged neonatal jaundice (HP:0006579) | 1.78741535 |
| 183 | Gowers sign (HP:0003391) | 1.77832644 |
| 184 | Adrenal hypoplasia (HP:0000835) | 1.77205410 |
| 185 | Ulnar claw (HP:0001178) | 1.77099003 |
| 186 | Increased corneal curvature (HP:0100692) | 1.76611883 |
| 187 | Keratoconus (HP:0000563) | 1.76611883 |
| 188 | Cupped ear (HP:0000378) | 1.75742581 |
| 189 | Abnormality of the 2nd finger (HP:0004100) | 1.74324394 |
| 190 | Myelomeningocele (HP:0002475) | 1.72361520 |
| 191 | Peripheral demyelination (HP:0011096) | 1.71209152 |
| 192 | Steppage gait (HP:0003376) | 1.69762263 |
| 193 | Mixed hearing impairment (HP:0000410) | 1.69461701 |
| 194 | Increased circulating renin level (HP:0000848) | 1.69246415 |
| 195 | Lower limb muscle weakness (HP:0007340) | 1.68207336 |
| 196 | Recurrent corneal erosions (HP:0000495) | 1.67997949 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | STK39 | 6.14525397 |
| 2 | IRAK3 | 5.44633588 |
| 3 | OXSR1 | 4.10218945 |
| 4 | MAP3K3 | 4.04655084 |
| 5 | MAP3K14 | 3.06595075 |
| 6 | EPHB1 | 2.98327040 |
| 7 | PKN1 | 2.87317407 |
| 8 | BCR | 2.73231856 |
| 9 | TBK1 | 2.72003881 |
| 10 | MAPKAPK5 | 2.65233522 |
| 11 | IRAK4 | 2.53595274 |
| 12 | TYK2 | 2.50859093 |
| 13 | PBK | 2.45013397 |
| 14 | IKBKE | 2.43684193 |
| 15 | MATK | 2.34500034 |
| 16 | WNK4 | 2.33192390 |
| 17 | MET | 2.29381827 |
| 18 | TAOK2 | 2.28876097 |
| 19 | IKBKB | 2.17810102 |
| 20 | WNK1 | 2.16853612 |
| 21 | LIMK1 | 2.15846045 |
| 22 | MST4 | 2.00852753 |
| 23 | FGFR2 | 1.96108135 |
| 24 | PNCK | 1.88761144 |
| 25 | RIPK1 | 1.86951131 |
| 26 | TGFBR2 | 1.86815489 |
| 27 | NME2 | 1.85917574 |
| 28 | CASK | 1.84283236 |
| 29 | NEK6 | 1.83112974 |
| 30 | RIPK4 | 1.82152794 |
| 31 | CDK19 | 1.81374647 |
| 32 | BLK | 1.76983919 |
| 33 | CSNK1A1L | 1.76362259 |
| 34 | CSNK1G3 | 1.71143863 |
| 35 | CSK | 1.70339311 |
| 36 | TESK2 | 1.69148647 |
| 37 | PIM2 | 1.68730439 |
| 38 | BMPR1B | 1.65075530 |
| 39 | CAMK2B | 1.64727679 |
| 40 | MAPK15 | 1.62142423 |
| 41 | JAK3 | 1.61331222 |
| 42 | JAK1 | 1.61119142 |
| 43 | ERN1 | 1.58308206 |
| 44 | CLK1 | 1.56310181 |
| 45 | MAP3K11 | 1.43218089 |
| 46 | CSNK1G1 | 1.43052774 |
| 47 | UHMK1 | 1.41594227 |
| 48 | ROCK2 | 1.41006249 |
| 49 | TXK | 1.39070089 |
| 50 | PRPF4B | 1.35273036 |
| 51 | CAMK2D | 1.33671334 |
| 52 | TAOK1 | 1.31707604 |
| 53 | TRPM7 | 1.27287325 |
| 54 | CHUK | 1.24983575 |
| 55 | FGR | 1.23794112 |
| 56 | NTRK1 | 1.23345395 |
| 57 | CSNK1G2 | 1.22502438 |
| 58 | MAP4K1 | 1.20289526 |
| 59 | SGK223 | 1.18861594 |
| 60 | SGK494 | 1.18861594 |
| 61 | CDC42BPA | 1.16971313 |
| 62 | DYRK2 | 1.16190325 |
| 63 | ABL2 | 1.13853127 |
| 64 | MAP3K1 | 1.11043900 |
| 65 | CAMK2G | 1.07555611 |
| 66 | PDGFRA | 1.06882002 |
| 67 | MAP2K3 | 1.06641560 |
| 68 | JAK2 | 1.03920863 |
| 69 | KIT | 1.03541487 |
| 70 | DDR2 | 1.00466727 |
| 71 | MAP3K9 | 0.98263109 |
| 72 | MUSK | 0.96980318 |
| 73 | ZAP70 | 0.91517255 |
| 74 | LATS2 | 0.91324183 |
| 75 | PAK3 | 0.87412782 |
| 76 | EPHA3 | 0.84231060 |
| 77 | CAMK2A | 0.83774109 |
| 78 | LYN | 0.83245781 |
| 79 | KSR2 | 0.82874677 |
| 80 | PRKCE | 0.80012278 |
| 81 | EPHA4 | 0.79881983 |
| 82 | ACVR1B | 0.79364108 |
| 83 | PRKCQ | 0.79316048 |
| 84 | MAPK4 | 0.77107273 |
| 85 | MARK1 | 0.75972037 |
| 86 | PRKD1 | 0.75115564 |
| 87 | TNIK | 0.74514531 |
| 88 | BMPR2 | 0.72678889 |
| 89 | PAK6 | 0.71994216 |
| 90 | BRAF | 0.71657450 |
| 91 | MAP3K5 | 0.70572303 |
| 92 | GSK3A | 0.70129235 |
| 93 | ERBB4 | 0.70043189 |
| 94 | MAP2K2 | 0.69706740 |
| 95 | MKNK1 | 0.68287675 |
| 96 | MARK2 | 0.68150742 |
| 97 | RPS6KA5 | 0.67974368 |
| 98 | CDK14 | 0.67561382 |
| 99 | STK24 | 0.64843419 |
| 100 | PHKG1 | 0.63874380 |
| 101 | PHKG2 | 0.63874380 |
| 102 | ICK | 0.63508649 |
| 103 | PLK2 | 0.60884997 |
| 104 | CDK5 | 0.59801354 |
| 105 | ARAF | 0.59771572 |
| 106 | CDK15 | 0.57462180 |
| 107 | MKNK2 | 0.57432203 |
| 108 | ADRBK2 | 0.57146568 |
| 109 | MOS | 0.56552698 |
| 110 | GRK7 | 0.56299951 |
| 111 | PRKG1 | 0.54798336 |
| 112 | TAOK3 | 0.53542642 |
| 113 | CDK18 | 0.53458209 |
| 114 | HCK | 0.53005626 |
| 115 | PIM1 | 0.51054467 |
| 116 | CDK11A | 0.50926517 |
| 117 | SIK3 | 0.49996613 |
| 118 | PRKCH | 0.49701047 |
| 119 | BMX | 0.48143485 |
| 120 | IRAK1 | 0.47446879 |
| 121 | PIK3CA | 0.47391869 |
| 122 | MARK3 | 0.47023041 |
| 123 | MAP3K13 | 0.46925533 |
| 124 | MAPK7 | 0.46330430 |
| 125 | CSNK1A1 | 0.45616928 |
| 126 | PAK2 | 0.45580602 |
| 127 | LCK | 0.45205094 |
| 128 | SYK | 0.45137686 |
| 129 | PTK2B | 0.44146084 |
| 130 | CSNK1D | 0.43912690 |
| 131 | RAF1 | 0.43761853 |
| 132 | IRAK2 | 0.41905957 |
| 133 | FYN | 0.41856734 |
| 134 | ABL1 | 0.40289831 |
| 135 | MAPK13 | 0.39981671 |
| 136 | TYRO3 | 0.39946994 |
| 137 | STK16 | 0.39589636 |
| 138 | PRKD2 | 0.39461821 |
| 139 | GRK1 | 0.39072895 |
| 140 | FGFR3 | 0.37994136 |
| 141 | DYRK3 | 0.37827572 |
| 142 | NEK9 | 0.37253723 |
| 143 | PDPK1 | 0.36327660 |
| 144 | DYRK1A | 0.36266936 |
| 145 | CAMK1D | 0.35996420 |
| 146 | EPHB2 | 0.35974406 |
| 147 | PRKACB | 0.35273894 |
| 148 | KSR1 | 0.35072077 |
| 149 | PDK1 | 0.32162495 |
| 150 | DAPK2 | 0.32134370 |
| 151 | PDGFRB | 0.31501990 |
| 152 | INSR | 0.31251012 |
| 153 | ITK | 0.30181267 |
| 154 | PRKACA | 0.29711632 |
| 155 | PAK1 | 0.28990289 |
| 156 | AKT3 | 0.28692790 |
| 157 | NTRK2 | 0.28131550 |
| 158 | STK10 | 0.27458860 |
| 159 | DMPK | 0.27074227 |
| 160 | OBSCN | 0.25755048 |
| 161 | MAP2K6 | 0.25665488 |
| 162 | HIPK2 | 0.25319761 |
| 163 | DAPK3 | 0.24779811 |
| 164 | ROCK1 | 0.23614392 |
| 165 | CSF1R | 0.22961200 |
| 166 | EIF2AK3 | 0.22322847 |
| 167 | PRKCD | 0.20797728 |
| 168 | FGFR4 | 0.20280553 |
| 169 | PRKAA2 | 0.20185798 |
| 170 | FRK | 0.18778072 |
| 171 | CDK6 | 0.18501647 |
| 172 | SGK3 | 0.18277699 |
| 173 | BTK | 0.16979407 |
| 174 | TESK1 | 0.16823013 |
| 175 | ADRBK1 | 0.16706468 |
| 176 | MAPK11 | 0.15815614 |
| 177 | EIF2AK2 | 0.15380413 |
| 178 | MAPK3 | 0.13827958 |
| 179 | NLK | 0.13338806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 4.56192235 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 4.05626756 |
| 3 | Steroid biosynthesis_Homo sapiens_hsa00100 | 3.71090151 |
| 4 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 3.39329083 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 3.16747177 |
| 6 | Ether lipid metabolism_Homo sapiens_hsa00565 | 3.11661945 |
| 7 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.97136571 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.80782409 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 2.79451814 |
| 10 | TNF signaling pathway_Homo sapiens_hsa04668 | 2.71397787 |
| 11 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.66830095 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.65925833 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.57592537 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 2.57253095 |
| 15 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.53316187 |
| 16 | Pertussis_Homo sapiens_hsa05133 | 2.49150492 |
| 17 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.24894808 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.18267158 |
| 19 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.15267006 |
| 20 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.07391961 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01835915 |
| 22 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.00989426 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.98434087 |
| 24 | Tuberculosis_Homo sapiens_hsa05152 | 1.93969745 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.88576014 |
| 26 | Other glycan degradation_Homo sapiens_hsa00511 | 1.87844853 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.86519266 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.84360537 |
| 29 | Influenza A_Homo sapiens_hsa05164 | 1.81312383 |
| 30 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.72179764 |
| 31 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.71975018 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.69471708 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.68638249 |
| 34 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.64669223 |
| 35 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.59947975 |
| 36 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.59629690 |
| 37 | Measles_Homo sapiens_hsa05162 | 1.59301137 |
| 38 | Axon guidance_Homo sapiens_hsa04360 | 1.54138491 |
| 39 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.52283104 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49655516 |
| 41 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.45646885 |
| 42 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.43357508 |
| 43 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.42668528 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.41172244 |
| 45 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.41146355 |
| 46 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.38680498 |
| 47 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36861673 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.32449206 |
| 49 | Hepatitis C_Homo sapiens_hsa05160 | 1.27711748 |
| 50 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.25532419 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.22706396 |
| 52 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.21749675 |
| 53 | Alzheimers disease_Homo sapiens_hsa05010 | 1.20599607 |
| 54 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.18608663 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18390518 |
| 56 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.17522690 |
| 57 | Parkinsons disease_Homo sapiens_hsa05012 | 1.16474851 |
| 58 | Hepatitis B_Homo sapiens_hsa05161 | 1.16124768 |
| 59 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12472400 |
| 60 | Shigellosis_Homo sapiens_hsa05131 | 1.11672416 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.05789661 |
| 62 | GABAergic synapse_Homo sapiens_hsa04727 | 1.05389990 |
| 63 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.02825872 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 1.02767842 |
| 65 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.94304370 |
| 66 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.94060072 |
| 67 | Morphine addiction_Homo sapiens_hsa05032 | 0.93071565 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.92322830 |
| 69 | Long-term depression_Homo sapiens_hsa04730 | 0.92018566 |
| 70 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88261299 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.87825074 |
| 72 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.87376802 |
| 73 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.87062339 |
| 74 | Bladder cancer_Homo sapiens_hsa05219 | 0.86335082 |
| 75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.85340036 |
| 76 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84540775 |
| 77 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.83812254 |
| 78 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.82457925 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.81674723 |
| 80 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.81630665 |
| 81 | Viral myocarditis_Homo sapiens_hsa05416 | 0.81046905 |
| 82 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80886308 |
| 83 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.79074297 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.79015834 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78659460 |
| 86 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.78577988 |
| 87 | Mineral absorption_Homo sapiens_hsa04978 | 0.77437711 |
| 88 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.77019703 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74196069 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.73975158 |
| 91 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.73504344 |
| 92 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.72549384 |
| 93 | Phototransduction_Homo sapiens_hsa04744 | 0.72393064 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.72232013 |
| 95 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.71726822 |
| 96 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.71597918 |
| 97 | Apoptosis_Homo sapiens_hsa04210 | 0.71452265 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71389257 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.70458097 |
| 100 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.67977428 |
| 101 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.66873292 |
| 102 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65783458 |
| 103 | Tight junction_Homo sapiens_hsa04530 | 0.64721966 |
| 104 | Prion diseases_Homo sapiens_hsa05020 | 0.62895292 |
| 105 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.62276124 |
| 106 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61536784 |
| 107 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.60507035 |
| 108 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.58528966 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58347387 |
| 110 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57696982 |
| 111 | Circadian entrainment_Homo sapiens_hsa04713 | 0.56742482 |
| 112 | Lysosome_Homo sapiens_hsa04142 | 0.55936594 |
| 113 | Salivary secretion_Homo sapiens_hsa04970 | 0.55501804 |
| 114 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55494383 |
| 115 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.54355061 |
| 116 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.54211838 |
| 117 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.54141028 |
| 118 | Huntingtons disease_Homo sapiens_hsa05016 | 0.53446674 |
| 119 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53168430 |
| 120 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.52673703 |
| 121 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52453284 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.51976207 |
| 123 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.49527702 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.47852110 |
| 125 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.47746058 |
| 126 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.45745030 |
| 127 | Asthma_Homo sapiens_hsa05310 | 0.45674645 |
| 128 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.45619023 |
| 129 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45352080 |
| 130 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.44780629 |
| 131 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.44775167 |
| 132 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44362980 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43472094 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43328883 |
| 135 | Salmonella infection_Homo sapiens_hsa05132 | 0.43241580 |
| 136 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42745603 |
| 137 | Endocytosis_Homo sapiens_hsa04144 | 0.41385396 |
| 138 | Amoebiasis_Homo sapiens_hsa05146 | 0.41004209 |
| 139 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40526260 |
| 140 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.39335550 |
| 141 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.38261856 |
| 142 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37945626 |
| 143 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.37813517 |
| 144 | Insulin resistance_Homo sapiens_hsa04931 | 0.36957361 |
| 145 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.36921782 |
| 146 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36198820 |
| 147 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.35847212 |
| 148 | Renin secretion_Homo sapiens_hsa04924 | 0.35678050 |
| 149 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35583132 |
| 150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.35545643 |
| 151 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.35211632 |
| 152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35165832 |
| 153 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.34649726 |
| 154 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.34280865 |
| 155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.33767868 |
| 156 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.33602965 |
| 157 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.33281622 |
| 158 | Nicotine addiction_Homo sapiens_hsa05033 | 0.32648341 |
| 159 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.32624686 |
| 160 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.31874452 |
| 161 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30926698 |
| 162 | HTLV-I infection_Homo sapiens_hsa05166 | 0.27417815 |
| 163 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.26852331 |
| 164 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24565340 |
| 165 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.24028264 |
| 166 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23952978 |
| 167 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.21953969 |
| 168 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.16535716 |
| 169 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.16071118 |
| 170 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.15039440 |
| 171 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.14606596 |
| 172 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13451950 |
| 173 | Prostate cancer_Homo sapiens_hsa05215 | 0.12533364 |

